1-6 of 6
Neil E. Kay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912

Clinical Trials & Observations
Tait D. Shanafelt, Xin Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan M. O'Brien, M.D., Jacqueline Claudia Barrientos, Diane F Jelinek, Esteban Braggio, Jose F. Leis, cong zhang, Paul M. Barr, Amanda F Cashen, Anthony R Mato, Avina K Singh, Michael Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R Litzow, Martin S. Tallman, Neil E. Kay
Journal: Blood Advances
Blood Adv bloodadvances.2024013474.
https://doi.org/10.1182/bloodadvances.2024013474
Published: 2024
Includes: Supplemental data
Journal Articles

Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis

Clinical Trials & Observations
Geffen Kleinstern, Nicholas J. Boddicker, Daniel R. O’Brien, Cristine Allmer, Kari G. Rabe, Aaron D. Norman, Rosalie Griffin, Huihuang Yan, Tao Ma, Timothy G. Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A. Hanson, Jose F. Leis, Wei Ding, Celine M. Vachon, Neil E. Kay, Christopher C. Oakes, Alexander S. Parker, Danielle M. Brander, J. Brice Weinberg, Richard R. Furman, Tait D. Shanafelt, James R. Cerhan, Sameer A. Parikh, Esteban Braggio, Susan L. Slager
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2118–2129.
https://doi.org/10.1182/bloodadvances.2023012242
Published: 2024
Includes: Supplemental data
Journal Articles

Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL

Rosalie Griffin, Julia E. Wiedmeier-Nutor, Sameer A. Parikh, Chantal E. McCabe, Daniel R. O'Brien, Nicholas J. Boddicker, Geffen Kleinstern, Kari G. Rabe, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Wei Ding, Jose F. Leis, Paul J. Hampel, Timothy G. Call, Daniel L. Van Dyke, Neil E. Kay, James R. Cerhan, Huihuang Yan, Susan L. Slager, Esteban Braggio
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3169–3179.
https://doi.org/10.1182/bloodadvances.2022009040
Published: 2023
Includes: Supplemental data
Journal Articles

Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19

Clinical Trials & Observations
Juan G. Ripoll, Ellen K. Gorman, Justin E. Juskewitch, Raymund R. Razonable, Ravindra Ganesh, Ryan T. Hurt, Elitza S. Theel, James R. Stubbs, Jeffrey L. Winters, Sameer A. Parikh, Neil E. Kay, Michael J. Joyner, Jonathon W. Senefeld
Journal: Blood Advances
Blood Adv (2022) 6 (23): 5951–5955.
https://doi.org/10.1182/bloodadvances.2022008932
Published: 2022
Journal Articles

The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites

Clinical Trials & Observations
Anthony Mato, Chadi Nabhan, Nicole Lamanna, Neil E. Kay, David L. Grinblatt, Christopher R. Flowers, Charles M. Farber, Matthew S. Davids, Arlene S. Swern, Kristen Sullivan, E. Dawn Flick, Sarah M. Gressett Ussery, Mecide Gharibo, Pavel Kiselev, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1407–1418.
https://doi.org/10.1182/bloodadvances.2019001145
Published: 2020
Includes: Supplemental data
Journal Articles

Early progression of disease as a predictor of survival in chronic lymphocytic leukemia

Clinical Trials & Observations
Inhye E. Ahn, Charles M. Farber, Matthew S. Davids, David L. Grinblatt, Neil E. Kay, Nicole Lamanna, Anthony Mato, Chadi Nabhan, Pavel Kiselev, Arlene S. Swern, E. Dawn Flick, Kristen Sullivan, Jeff P. Sharman, Christopher R. Flowers
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2433–2443.
https://doi.org/10.1182/bloodadvances.2017011262
Published: 2017
Includes: Supplemental data